Related Experiment Video

Updated: Nov 2, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K

Epidemiology of Reported HIV and Other Sexually Transmitted Infections During the COVID-19 Pandemic, New York City

Sarah L Braunstein1, Jennifer Sanderson Slutsker2, Rachael Lazar1

  • 1Bureau of HIV, New York City Department of Health and Mental Hygiene, New York, New York, USA.

The Journal of Infectious Diseases
|June 16, 2021
PubMed

Insights

The COVID-19 lockdown in New York significantly reduced diagnoses of HIV and other sexually transmitted infections. Cases declined sharply during the PAUSE order, with some changes in patient characteristics observed.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic prompted unprecedented public health interventions, including lockdowns.
  • The New York on PAUSE (Policies to Accelerate and Comprehend Our Economic response) order restricted movement from March 23 to June 7, 2020.

Purpose of the Study:

  • To analyze the impact of the COVID-19 PAUSE order on the diagnosis and reporting of HIV and STIs in New York City.
  • To identify trends and shifts in STI and HIV cases during the early pandemic period.

Main Methods:

  • Utilized New York City surveillance data for HIV, chlamydia, gonorrhea, and syphilis.
  • Described diagnostic and reporting trends during the PAUSE period (March 23–June 7, 2020).

Main Results:

  • A substantial decline in the volume of positive HIV/STI tests and diagnoses occurred during the PAUSE order.
  • Diagnoses reached a low point in April 2020 before beginning to rebound.
  • Observed some shifts in the characteristics of reported cases during this period.

Conclusions:

  • The COVID-19 PAUSE order was associated with a significant, albeit temporary, reduction in HIV and STI diagnoses in New York City.
  • Understanding these trends is crucial for public health planning and resource allocation during public health emergencies.

Keywords:
2COVID-19CoVHIVSARSsexually transmitted infectionssurveillance

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.8K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.3K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
519
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.5K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.0K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.9K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.3K